GeekWire: Diagnostics startup ID Genomics snags NIH grant to develop rapid test for COVID-19 variants

Diagnostics startup ID Genomics will accelerate its development of a quick test for variants of the COVID-19 virus with a new grant from the U.S. National Institutes of Health. The Seattle-based company announced the $300,000 small business grant Tuesday for the dipstick-based test, currently dubbed CovNET. ID Genomics is also eligible for a follow-on grant of up to $3 million.

Read the full article on GeekWire.

Interested in Becoming a Community Partner?

The Fourth Industrial Revolution may be one of the most important conversations of our time.

Help bring next-generation technologies to the US by becoming a Seattle Community partner.